We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
+17.83%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$16B
AUM Growth
+$1.78B
Cap. Flow
+$33.6M
Cap. Flow %
0.21%
Top 10 Hldgs %
65.86%
Holding
407
New
22
Increased
83
Reduced
147
Closed
77

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$237M
2
MA icon
Mastercard
MA
+$117M
3
WSE
Wise Group
WSE
+$21.4M
4
TW icon
Tradeweb Markets
TW
+$19M
5
PH icon
Parker-Hannifin
PH
+$18.9M

Sector Composition

Rank Sector Weight
1 Technology 16.55%
2 Consumer Discretionary 10.11%
3 Healthcare 8.38%
4 Communication Services 8.16%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
76
Humana
HUM
$46.3B
$16.5M 0.1%
41,423
-8,848
-18% -$2.52M
EEM icon
77
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$16.3M 0.1%
238,928
+33,226
+16% +$2.17M
EXPE icon
78
Expedia Group
EXPE
$37.7B
$16.2M 0.1%
63,438
-7,039
-10% -$1.67M
PG icon
79
Procter & Gamble
PG
$340B
$15.4M 0.1%
104,827
-216
-0.2% -$31.4K
ABT icon
80
Abbott
ABT
$188B
$14.9M 0.09%
164,459
+40,282
+32% +$3.68M
CQQQ icon
81
Invesco China Technology ETF
CQQQ
$3.3B
$14.8M 0.09%
259,878
-47,039
-15% -$2.43M
ISRG icon
82
Intuitive Surgical
ISRG
$139B
$14.7M 0.09%
36,949
+4,888
+15% +$2.14M
DG icon
83
Dollar General
DG
$27B
$14.1M 0.09%
122,683
+6,529
+6% +$742K
JPM icon
84
JPMorgan Chase
JPM
$956B
$14.1M 0.09%
43,013
-13,416
-24% -$4.17M
BIIB icon
85
Biogen
BIIB
$30.6B
$14.1M 0.09%
65,080
-981
-1% -$188K
ABNB icon
86
Airbnb
ABNB
$111B
$13.5M 0.08%
94,574
-14,069
-13% -$1.92M
EWT icon
87
iShares MSCI Taiwan ETF
EWT
$11B
$13.4M 0.08%
123,810
-20,412
-14% -$1.91M
AFL icon
88
Aflac
AFL
$61.2B
$13.2M 0.08%
112,822
-1,804
-2% -$208K
SCHW
89
Charles Schwab
SCHW
$188B
$12.9M 0.08%
140,236
-5,015
-3% -$457K
SOPH icon
90
SOPHiA GENETICS
SOPH
$643M
$12.7M 0.08%
2,208,280
TMO icon
91
Thermo Fisher Scientific
TMO
$222B
$12.7M 0.08%
25,321
+1,335
+6% +$641K
CME icon
92
CME Group
CME
$94.8B
$12.5M 0.08%
56,727
-2,483
-4% -$687K
SW
93
Smurfit Westrock
SW
$25B
$12.4M 0.08%
268,895
-54,030
-17% -$2.23M
PKG icon
94
Packaging Corp of America
PKG
$22.7B
$12.3M 0.08%
51,728
-1,003
-2% -$220K
FCX icon
95
Freeport-McMoran
FCX
$98.7B
$12.3M 0.08%
195,695
-49,867
-20% -$3.21M
NVR icon
96
NVR
NVR
$16.8B
$11.8M 0.07%
1,734
+120
+7% +$762K
VRTX icon
97
Vertex Pharmaceuticals
VRTX
$133B
$11.7M 0.07%
23,496
-5,054
-18% -$2.24M
ZM icon
98
Zoom
ZM
$31.4B
$11.5M 0.07%
133,775
-2,196
-2% -$208K
NEM icon
99
Newmont
NEM
$124B
$11.4M 0.07%
122,000
-55,734
-31% -$6.07M
QCOM icon
100
Qualcomm
QCOM
$170B
$11.2M 0.07%
60,815
-24,609
-29% -$4.6M

Similar funds

Banque Pictet & Cie's Q2 2026 Portfolio in Review

As of Q2 2026, Banque Pictet & Cie held 407 positions worth $16B, up 13% from $14.2B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Banque Pictet & Cie's Q2 2026 filing shows 22 new, 83 increased, 147 reduced and 77 closed positions. Its largest new stake was Wise Group: 1,795,190 shares worth $21.5M. The largest sale was Alphabet (Google) Class C, an estimated $96.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Banque Pictet & Cie's largest Q2 2026 buy was Wise Group: 1,795,190 shares worth $21.5M.
  • Banque Pictet & Cie added most to Medline Inc in Q2 2026, an estimated $237M increase.
  • Banque Pictet & Cie's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $96.4M.
  • Banque Pictet & Cie fully exited Global X Artificial Intelligence & Technology ETF in Q2 2026, selling an estimated $17.7M.
  • Banque Pictet & Cie's ten largest holdings make up 66% of its $16B portfolio in Q2 2026.
  • Banque Pictet & Cie opened 22 new positions and closed 77 in Q2 2026.
  • Banque Pictet & Cie's portfolio value rose 13% quarter-over-quarter to $16B.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.